United States · FDA National Drug Code directory
RABEPRAZOLE SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0363_2a998081-6423-8228-e063-6294a90adc3d
- Product NDC
- 80425-0363
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- rabeprazole sodium
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231023
- Source listing expiry
- 20261231
Source-listed ingredients
- RABEPRAZOLE SODIUM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0363-1) · 80425-0363-1
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0363-2) · 80425-0363-2
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0363-3) · 80425-0363-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →